Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 12, 2011, Pages 3536-3540

  Musad, Ebraheem Abdu ^a   Mohamed, Riyaz ^a   Ali Saeed, Bahjat ^b   Vishwanath, Bannikuppe S ^a   Lokanatha Rai, K M ^a  

^a UNIVERSITY OF MYSORE   (India)

^b UNIVERSITY OF BASRAH   (Iraq)

Author keywords

3,5 Bis(substituted) pyrazoles; Antibacterial; Antioxidant; Isoxazoles; Methylene linked bis(1,3,4 oxadiazole) derivatives

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ALPHA TOCOPHEROL; ANTIINFECTIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; BIS(1,3,4 OXADIAZOLE) DERIVATIVE; CIPROFLOXACIN; HYDRAZONE DERIVATIVE; HYDROXYLAMINE; ISOXAZOLE DERIVATIVE; PYRAZOLE DERIVATIVE; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CARBON NUCLEAR MAGNETIC RESONANCE; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; LIPID PEROXIDATION; NONHUMAN; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SUBSTITUTION REACTION;

ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; BACTERIA; ISOXAZOLES; LIPID PEROXIDATION; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; OXADIAZOLES; PYRAZOLES;

EID: 79957811028     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.04.142     Document Type: Article

References (27)

1. He, D. H.; Zhu, Y. C.; Yang, Z. R.; Xihu, A. J. Chin. Chem. Soc. 2009, 56, 268.
2. Tully, W. R.; Gardner, C. R.; Gillespie, R. J.; Westwood, R. J. Med. Chem. 1991, 34, 2060.
3. Bhatt, J. J.; Shah, B. R.; Shah, H. P.; Trivedi, P. B.; Undavia, N. K.; Desai, N. C. J. Indian Chem. 1994, 33B, 189.
4. Kumar, A.; D'Souza, S. S.; Gaonkar, S. L.; Rai, K. M.; Salimath, B. P. Invest. New Drugs 2008, 26, 425.
5. Manfrendini, S.; Bazzanini, R.; Baraldi, P.; Bonora, M.; Marangoni, M.; Simoni, D.; Pani, A.; Scintu, F.; Pinna, E.; Pisana, L.; Lo-Colla, P. Anticancer Drug Res. 1996, 11, 193.
6. Lee, Y. S.; Park, S. M.; Kim, H. M.; Park, S. K.; Lee, K. Bioorg. Med. Chem. Lett. 2009, 19, 4688.
7. Anjani, S.; Yogesh, P. R. Rasayan J. Chem. 2009, 2, 23.
8. Kang, A. Y.; Shin, J. K.; Yoo, H. K.; Seo, J. K. Bioorg. Med. Chem. Lett. 2000, 10, 95.
9. Bondock, S.; Fadaly, W.; Metwally, M. A. Eur. J. Med. Chem. 2009, 44, 4813.
10. Manojkumar, P.; Ravi, T. K.; Chettiar, G. S. Acta Pharm. 2009, 55, 159.
11. Rajasekaran, S.; Rao, G. K.; Pai, S.; Vedavathy, J. J. Chem. Pharm. Res. 2010, 2, 101.
12. Zheng, X.; Li, Z.; Wang, Y.; Chen, W.; Huang, O.; Liu, C.; Song, C. J. Fluorine Chem. 2003, 123, 163.
13. Li, Y.; Zhang, Q. H.; Liu, J.; Yang, X. P.; Liu, Z. J. J. Agric. Food Chem. 2006, 54, 3636.
14. Siddall, T. L.; Quse, D. G.; Benko, Z. L.; Garvin, G. M.; Jackson, J. L.; McQuiston, J. M.; Ricks, M. J.; Thibault, T. D.; Tumer, J. A.; VanHeertum, J. C.; Weimer, M. R. Pest Manag. Sci. 2002, 58, 1175.
15. Khan, K. M.; Zia Ullah; Rani, M.; Perveen, S.; Haider, S. M.; Choudary, M. I.; Attaur-Rahman; Voelter, W. Lett. Org. Chem. 2004, 1, 50.
16. Liras, S.; Allen, M. P.; Segelstein, B. E. Synth. Commun. 2000, 30, 437.
17. Gaonkar, S. L.; Rai, K. M. L.; Prabhuswamy, B. Eur. J. Med. Chem. 2004, 41, 841.
18. Nishiyama, Y. N.; Nishimura, N.; Kuroyanagi, N.; Macba, I. Carbohydr. Res. 1995, 290, 507.
19. Moreira, D. N.; Longhi, K. L.; Fizzo, C. P.; Bonacorso, H. G.; Zanatta, N.; Martins, M. A. P. Catal. Commun. 2010, 11, 476.
20. Rai, K. M. L.; Linganna, N.; Hassner, A.; Anjanamurthy, C. J. Sci. Soc. Thailand 1996, 22, 71.
21. Musad, E. A.; Rai, K. M. L.; Pyrappa, K. Int. J. Biomed. Sci. 2010, 6, 100.
22. Rajavel, R.; Senthil, C. M. S.; Antha, C. E.-J. Chem. 2008, 5, 620.
23. Vijay Kumar, H.; Naik, N. Eur. J. Med. Chem. 2010, 45, 2.
24. Blois, M. S. Nature 1957, 181, 1199.
25. Ruberto, G.; Baratta, M. T.; Deans, S. G.; Dorman, H. J. Planta Med. 2000, 66, 687.
26. Andrews, J. M.BSAC Working Party on Susceptibility Testing J. Antimicrob. Chemother. 2008, 62, 256.
27. Experimental details and characterization data for new compounds are provided in the Supplementary data.